Latest News about RARE
Recent news which mentions RARE
From Benzinga
FDA Delays Approval For Ultragenyx's Gene Therapy, But Not A Dealbreaker, Says Analyst
July 14, 2025
From Benzinga
Ultragenyx Pharmaceutical, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session
July 14, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
US Stocks Mixed; Initial Jobless Claims Fall
July 10, 2025
From Benzinga
From Benzinga
From Benzinga
Methode Electronics, Ultragenyx Pharmaceutical And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
July 10, 2025
From Benzinga
Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket
July 10, 2025
From Benzinga
From Benzinga
Analyst Bullish On Ultragenyx, Poised For Growth With Six Drug Approvals Expected By 2028
May 28, 2025
From Benzinga
Earnings Scheduled For May 6, 2025
May 06, 2025
From Benzinga
From Benzinga
Ultragenyx Stays On JPMorgan's Focus List As Analyst Highlights Strong Long-Term Positioning
March 27, 2025
From Benzinga
Breaking Down Ultragenyx Pharmaceutical: 7 Analysts Share Their Views
February 14, 2025
Tickers
RARE
From Benzinga
Earnings Scheduled For February 13, 2025
February 13, 2025
From Benzinga
Ultragenyx's Multiple Commercial Assets And Candidates Impress Analyst; Sees Solid Upside
January 15, 2025
From Benzinga
From Benzinga
Evaluating Ultragenyx Pharmaceutical: Insights From 7 Financial Analysts
November 06, 2024
Tickers
RARE
From Benzinga
A Look Ahead: Ultragenyx Pharmaceutical's Earnings Forecast
November 04, 2024
Tickers
RARE
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.